Diagnostic Testing for Hepatitis C Virus in the Era of Direct-Acting Antiviral Therapy

  • Duration: 72 Minutes

Price: $69.00

Member Price: $59.00

This webcast originally aired as a live webinar sponsored by AACC on December 10, 2013. During this program, Dr. Alexandra Valsamakis, Director, Clinical Virology and Molecular Microbiology at The Johns Hopkins Hospital in Baltimore, describes how new CDC hepatitis C virus (HCV) screening recommendations and new, highly effective antiviral therapies are changing how clinicians test and treat people with, or suspected of having HCV.